Amway (Malaysia) Holdings Berhad operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Amway (Malaysia) Holdings Berhad with three other
drug stores in Asia:
Hemas Holdings Plc
of SRI LANKA
(2020
sales of 61.63 billion Sri Lanka Rupees [US$311.24 million]
of which 51%
was Health Care),
PKU HealthCare Corp Ltd
of CHINA
(1.96 billion Chinese Renmimbi [US$306.66 million]
), and
Sinco Pharmaceuticals Holdings Ltd
which is
based in HONG KONG
(2.31 billion Hong Kong Dollars [US$297.48 million]
of which 92%
was Human Albumin Solution).
Sales Analysis.
During the first
quarter of 2021, sales at Amway (Malaysia) Holdings Berhad totalled
353.65 million Malaysian Ringgits.
This is
an increase of 50.7%
from the 234.64 million Malaysian Ringgits in sales at the company during the first quarter of 2020.
This was the largest same quarter increase in sales since the first
quarter of 2015.
Amway (Malaysia) Holdings Berhad reported sales of 1.15 billion Malaysian Ringgits (US$280.18 million)
for the
year ending
December of 2020.
This
represents
an
increase of 19.4%
versus 2019, when the company's sales were 966.33 million Malaysian Ringgits.